{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:37:04Z","timestamp":1793025424466,"version":"4.5.0"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Polypharmacy are commonly observed among older adults with cardiovascular disease. However, multiple medications lead to increased risk of drug-drug interactions (DDIs). Therefore, identification and prevention actions related to harmful DDIs are expected in older adults. The study aimed to describe the prevalence of potential DDIs (pDDIs) in discharge prescriptions among older adults with chronic coronary syndrome (CCS).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A single-center cross-sectional study was performed in a tertiary public hospital in Beijing, China. CCS patients aged 65\u00a0years and above who were admitted to cardiology wards over a 3-month period and alive at discharge were included. Electronic medical records and discharge prescriptions were reviewed. pDDIs were evaluated through the Lexi-Interact online.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> pDDIs were identified in 72.9% of the 402 individuals (<jats:italic>n<\/jats:italic> = 293). A total of 864 pDDIs were obtained. 72.1% of patients were found with C DDIs (<jats:italic>n<\/jats:italic> = 290) and 20.3% were categorized in D and X DDIs (<jats:italic>n<\/jats:italic> = 82). The only X DDI was between cyclosporine and atorvastatin. Under category D, glycemia alterations within antidiabetics and increased chances of bleeding with antithrombotic were the most common. Concomitant use of clopidogrel and calcium channel blockers was a frequent situation within category C, followed by synergic blood pressure lowering agents and increased rosuvastatin concentration induced by clopidogrel.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> DDIs exposure was common in older CCS. DDIs screening tools should be introduced to alert potential adverse effects. Prescribers need to rigorously review or modulate therapies to prevent DDI-related adverse outcomes. Clinical pharmacists should be more involved in complex drug regimen management.<\/jats:p>","DOI":"10.3389\/fphar.2022.946415","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T07:33:38Z","timestamp":1661326418000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study"],"prefix":"10.3389","volume":"13","author":[{"given":"Mei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Fen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Fei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"8257","DOI":"10.3390\/ijerph18168257","article-title":"Older adults with hypertension: Prevalence of falls and their associated factors","volume":"18","author":"Abu","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1097\/MJT.0000000000000225","article-title":"Effects of concurrent calcium channel blocker on antiplatelet efficacy of clopidogrel therapy: A systematic review","volume":"23","author":"Aggarwal","year":"2016","journal-title":"Am. J. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.5005\/jp-journals-10071-23919","article-title":"Management of drug-drug interactions among critically ill patients with chronic kidney disease: Impact of clinical pharmacist's interventions","volume":"25","author":"Aghili","year":"2021","journal-title":"Indian J. Crit. Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40545-021-00348-1","article-title":"Potential drug-drug interactions in patients with cardiovascular diseases: Findings from a prospective observational study","volume":"14","author":"Akbar","year":"2021","journal-title":"J. Pharm. Policy Pract."},{"key":"B5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s40266-015-0263-z","article-title":"Current pharmacological management of hypotensive syndromes in the elderly","volume":"32","author":"Alagiakrishnan","year":"2015","journal-title":"Drugs Aging"},{"key":"B6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s40264-020-00918-3","article-title":"Prevalence and nature of medication errors and medication-related harm following discharge from hospital to community settings: A systematic review","volume":"43","author":"Alqenae","year":"2020","journal-title":"Drug Saf."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.jamda.2021.03.019","article-title":"An international consensus list of potentially clinically significant drug-drug interactions in older people","volume":"22","author":"Anrys","year":"2021","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of Carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: A randomized controlled trial","volume":"292","author":"Bakris","year":"2004","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0167-5273(15)31026-3","article-title":"Global burden of CVD: Focus on secondary prevention of cardiovascular disease","volume":"201","author":"Bansilal","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/pds.1351","article-title":"Hospitalisations and emergency department visits due to drug-drug interactions: A literature review","volume":"16","author":"Becker","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B11","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jgo.2019.07.023","article-title":"Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: A survey of the prospective elcapa (ELderly CAncer PAtients) cohort","volume":"11","author":"Beinse","year":"2020","journal-title":"J. Geriatr. Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/14740338.2018.1394455","article-title":"Statin drug interactions and related adverse reactions: An update","volume":"17","author":"Bellosta","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"B13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/5584_2020_494","article-title":"GLP-1 receptor agonists and SGLT2 inhibitors for the treatment of type 2 diabetes: New insights and opportunities for cardiovascular protection","volume":"1307","author":"Bertoccini","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1186\/s12859-019-3284-5","article-title":"Evaluation of knowledge graph embedding approaches for drug-drug interaction prediction in realistic settings","volume":"20","author":"Celebi","year":"2019","journal-title":"BMC Bioinforma."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.26355\/eurrev_202109_26798","article-title":"Evaluation of potential drug-drug interactions in intensive care unit","volume":"25","author":"Dagdelen","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/bcp.12596","article-title":"Adverse drug reactions in special populations - the elderly","volume":"80","author":"Davies","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.5543\/tkda.2021.21869","article-title":"Effects of new drug interaction index on drug adherence in older patients with hypertension","volume":"49","author":"Ersoy","year":"2021","journal-title":"Turk Kardiyol. Dern. Ars."},{"key":"B19","doi-asserted-by":"publisher","first-page":"100554","DOI":"10.1016\/j.cpcardiol.2020.100554","article-title":"The new ESC guidelines for the diagnosis and management of chronic coronary syndromes: The good and the not so good","volume":"46","author":"Ferrari","year":"2021","journal-title":"Curr. Probl. Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.11604\/pamj.2018.29.225.14169","article-title":"Detection and analysis of drug-drug interactions among hospitalized cardiac patients in the mohammed V military teaching hospital in Morocco","volume":"29","author":"Fettah","year":"2018","journal-title":"Pan Afr. Med. J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.jacc.2018.03.022","article-title":"Multimorbidity in older adults with cardiovascular disease","volume":"71","author":"Forman","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00228-011-1105-5","article-title":"Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis","volume":"68","author":"Franz","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejim.2019.05.002","article-title":"Drug-drug interactions involving CYP3A4 and P-glycoprotein in hospitalized elderly patients","volume":"65","author":"Gallo","year":"2019","journal-title":"Eur. J. Intern. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"104266","DOI":"10.1016\/j.ijmedinf.2020.104266","article-title":"Adverse events targeted by drug-drug interaction alerts in hospitalized patients","volume":"143","author":"Gatenby","year":"2020","journal-title":"Int. J. Med. Inf."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2050312119860401","DOI":"10.1177\/2050312119860401","article-title":"Drug therapy problems among patients with cardiovascular disease admitted to the medical ward and had a follow-up at the ambulatory clinic of hiwot fana specialized university hospital: The case of a tertiary hospital in eastern Ethiopia","volume":"7","author":"Gelchu","year":"2019","journal-title":"SAGE Open Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.rce.2019.05.011","article-title":"Prescription patterns of antihyperglycemic drugs in elderly patients in Spain: A national cross-sectional study","volume":"220","author":"G\u00f3mez-Huelgas","year":"2020","journal-title":"Rev. Clin. Esp."},{"key":"B27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/CIRCINTERVENTIONS.111.963405","article-title":"Is there a clinically significant interaction between calcium channel antagonists and clopidogrel?: Results from the clopidogrel for the reduction of events during observation (CREDO) trial","volume":"5","author":"Good","year":"2012","journal-title":"Circ. Cardiovasc. Interv."},{"key":"B28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s40801-021-00288-x","article-title":"Pharmaceutical interventions on hospital discharge prescriptions: Prospective observational study highlighting challenges for community pharmacists","volume":"9","author":"Grandchamp","year":"2022","journal-title":"Drugs Real World Outcomes"},{"key":"B29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/1755-5922.12138","article-title":"Calcium-channel blockers attenuate the antiplatelet effect of clopidogrel","volume":"33","author":"Gremmel","year":"2015","journal-title":"Cardiovasc. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ajem.2020.10.022","article-title":"Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis","volume":"46","author":"Hessami","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.amjopharm.2011.10.004","article-title":"Potentially harmful drug-drug interactions in the elderly: A review","volume":"9","author":"Hines","year":"2011","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1177\/1060028019863419","article-title":"The effect of patient-specific drug-drug interaction alerting on the frequency of alerts: A pilot study","volume":"53","author":"Horn","year":"2019","journal-title":"Ann. Pharmacother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3390\/medicina55110721","article-title":"Treatment with statins in elderly patients","volume":"55","author":"Horodinschi","year":"2019","journal-title":"Med. Kaunas."},{"key":"B34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.maturitas.2017.08.006","article-title":"Drugs and hyperglycemia: A practical guide","volume":"104","author":"Jain","year":"2017","journal-title":"Maturitas"},{"key":"B35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4103\/2279-042X.192461","article-title":"A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness","volume":"5","author":"Kheshti","year":"2016","journal-title":"J. Res. Pharm. Pract."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00228-019-02751-9","article-title":"National trends in metformin-based combination therapy of oral hypoglycaemic agents for type 2 diabetes mellitus","volume":"75","author":"Kim","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s11096-019-00951-y","article-title":"Potential drug-drug interactions associated with clinical and laboratory findings at hospital admission","volume":"42","author":"Kova\u010devi\u0107","year":"2020","journal-title":"Int. J. Clin. Pharm."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0220071","DOI":"10.1371\/journal.pone.0220071","article-title":"Prevalence and risk factors of drug-related hospitalizations in multimorbid patients admitted to an internal medicine ward","volume":"14","author":"Lea","year":"2019","journal-title":"PLoS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3928\/02793695-20200117-02","article-title":"Adverse events, drug interactions, and treatment adherence","volume":"58","author":"Limandri","year":"2020","journal-title":"J. Psychosoc. Nurs. Ment. Health Serv."},{"key":"B41","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ajem.2021.04.054","article-title":"Implementation of pharmacist targeted discharge prescription review in an emergency department","volume":"48","author":"Lineberry","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1001\/jamacardio.2019.6175","article-title":"Optimal antithrombotic regimens for patients with atrial fibrillation undergoing percutaneous coronary intervention: An updated network meta-analysis","volume":"5","author":"Lopes","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1517\/14740338.2012.631910","article-title":"Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions","volume":"11","author":"Magro","year":"2012","journal-title":"Expert Opin. Drug Saf."},{"key":"B44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1515\/dmpt-2020-0145","article-title":"Clinically important drug-drug interactions in patients admitted to hospital with COVID-19: Drug pairs, risk factors, and management","volume":"36","author":"Mahboobipour","year":"2021","journal-title":"Drug Metabol. Drug Interact."},{"key":"B45","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41397-019-0122-0","article-title":"Drug-drug-gene interactions and adverse drug reactions","volume":"20","author":"Malki","year":"2020","journal-title":"Pharmacogenomics J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.advms.2017.06.005","article-title":"Patients with atrial fibrillation and coronary artery disease - double trouble","volume":"63","author":"Michniewicz","year":"2018","journal-title":"Adv. Med. Sci."},{"key":"B47","first-page":"185","article-title":"Drug-drug interactions among kidney transplant recipients in the outpatient setting","volume":"11","author":"Moradi","year":"2020","journal-title":"Int. J. Organ Transpl. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"266","DOI":"10.18433\/j35c7z","article-title":"Drug-drug interactions associated with length of stay and cost of hospitalization","volume":"12","author":"Moura","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/S0140-6736(21)01920-6","article-title":"Blood pressure lowering and risk of new-onset type 2 diabetes: An individual participant data meta-analysis","volume":"398","author":"Nazarzadeh","year":"2021","journal-title":"Lancet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jgo.2018.02.001","article-title":"The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software","volume":"9","author":"Nightingale","year":"2018","journal-title":"J. Geriatr. Oncol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"715577","DOI":"10.3389\/fphar.2021.715577","article-title":"Evaluation of a clinically relevant drug-drug interaction between rosuvastatin and clopidogrel and the risk of hepatotoxicity","volume":"12","author":"Ning","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/clc.23303","article-title":"Hypertension in older adults: Assessment, management, and challenges","volume":"43","author":"Oliveros","year":"2020","journal-title":"Clin. Cardiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11739-018-1994-8","article-title":"Drug-drug interactions in patients with acute coronary syndrome across phases of treatment","volume":"14","author":"Pej\u010di\u0107","year":"2019","journal-title":"Intern. Emerg. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijcard.2012.04.051","article-title":"Pharmacokinetic interactions between clopidogrel and rosuvastatin: Effects on vascular protection in subjects with coronary heart disease","volume":"158","author":"Pinheiro","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.clinthera.2020.02.005","article-title":"Drug-related problems in home-dwelling older adults: A systematic review","volume":"42","author":"Pl\u00e1cido","year":"2020","journal-title":"Clin. Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0140-6736(14)61347-7","article-title":"The burden of disease in older people and implications for health policy and practice","volume":"385","author":"Prince","year":"2015","journal-title":"Lancet"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1093\/oncolo\/oyac053","article-title":"Polypharmacy, potentially inappropriate medications, and drug-drug interactions in vulnerable older adults with advanced cancer initiating cancer treatment","volume":"27","author":"Ramsdale","year":"2022","journal-title":"Oncologist"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1007\/s11096-020-01068-3","article-title":"Prevalence of potential drug-drug interactions in outpatients of a general hospital in China: A retrospective investigation","volume":"42","author":"Ren","year":"2020","journal-title":"Int. J. Clin. Pharm."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e12944","DOI":"10.1111\/ecc.12944","article-title":"Drug interactions with oral antineoplastic drugs: The role of the pharmacist","volume":"28","author":"Riu-Viladoms","year":"2019","journal-title":"Eur. J. Cancer Care"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.3390\/diagnostics11101762","article-title":"Planning the follow-up of patients with stable chronic coronary artery disease","volume":"11","author":"Romero-Farina","year":"2021","journal-title":"Diagn. (Basel)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e0236830","DOI":"10.1371\/journal.pone.0236830","article-title":"Drug related problems in older adults living with dementia","volume":"15","author":"Ruangritchankul","year":"2020","journal-title":"PLoS One"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e0237781","DOI":"10.1371\/journal.pone.0237781","article-title":"Evaluation of drug therapy problems, medication adherence and treatment satisfaction among heart failure patients on follow-up at a tertiary care hospital in Ethiopia","volume":"15","author":"Seid","year":"2020","journal-title":"PLoS One"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1001\/jama.2016.16201","article-title":"US emergency department visits for outpatient Adverse drug events, 2013-2014","volume":"316","author":"Shehab","year":"2016","journal-title":"JAMA"},{"key":"B64","doi-asserted-by":"publisher","first-page":"5728957","DOI":"10.1155\/2018\/5728957","article-title":"Evaluation of potential drug-drug interactions with medications prescribed to geriatric patients in a tertiary care hospital","volume":"2018","author":"Shetty","year":"2018","journal-title":"J. Aging Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s00059-019-04862-6","article-title":"ESC guidelines 2019 on chronic coronary syndrome (CCS, previously \"stable coronary artery disease\"): What is new? What is particularly important?","volume":"44","author":"Silber","year":"2019","journal-title":"Herz"},{"key":"B66","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11096-014-0063-2","article-title":"Drug-related problems in institutionalized, polymedicated elderly patients: Opportunities for pharmacist intervention","volume":"37","author":"Silva","year":"2015","journal-title":"Int. J. Clin. Pharm."},{"key":"B67","first-page":"60","article-title":"Polypharmacy and drug use pattern among Indonesian elderly patients visiting emergency unit","volume":"53","author":"Soejono","year":"2021","journal-title":"Acta Med. Indones."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s00228-018-2514-5","article-title":"Clinically relevant drug-drug interactions among elderly people with dementia","volume":"74","author":"S\u00f6nnerstam","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1345\/aph.1H658","article-title":"Systematic review of the incidence and characteristics of preventable Adverse drug events in ambulatory care","volume":"41","author":"Thomsen","year":"2007","journal-title":"Ann. Pharmacother."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2147\/TCRM.S337256","article-title":"Drug-related problems among ambulatory heart failure patients on follow-up at debre berhan comprehensive specialized hospital, Ethiopia","volume":"17","author":"Tsige","year":"2021","journal-title":"Ther. Clin. Risk Manag."},{"key":"B72","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/phar.1395","article-title":"Analysis of potential drug-drug interactions in medical intensive care unit patients","volume":"34","author":"Uijtendaal","year":"2014","journal-title":"Pharmacotherapy"},{"key":"B73","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/1078155217717324","article-title":"Prevalence study on potential drug-drug interaction in cancer patients in piacenza hospital's onco-haematology department","volume":"24","author":"Vecchia","year":"2018","journal-title":"J. Oncol. Pharm. Pract."},{"key":"B74","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1590\/1413-81232018241.32602016","article-title":"Factors associated with drug interactions in elderly hospitalized in high complexity hospital","volume":"24","author":"Veloso","year":"2019","journal-title":"Cien. Saude Colet."},{"key":"B75","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/TCRM.S80437","article-title":"Pharmacokinetic drug interactions with clopidogrel: Updated review and risk management in combination therapy","volume":"11","author":"Wang","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"B76","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1161\/CIRCULATIONAHA.118.035858","article-title":"Current status of cardiovascular medicine in the aging society of Japan","volume":"138","author":"Yasuda","year":"2018","journal-title":"Circulation"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1111\/ggi.13495","article-title":"Factors associated with potentially harmful drug-drug interactions in older Korean people: A population-based study","volume":"18","author":"Yoon","year":"2018","journal-title":"Geriatr. Gerontol. Int."},{"key":"B78","doi-asserted-by":"publisher","first-page":"467","DOI":"10.34172\/hpp.2021.59","article-title":"Experience of adherence to treatment among patients with coronary artery disease during the COVID-19 pandemic: A qualitative study","volume":"11","author":"Zahmatkeshan","year":"2021","journal-title":"Health promot. Perspect."},{"key":"B79","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41569-018-0119-4","article-title":"Epidemiology of cardiovascular disease in China: Current features and implications","volume":"16","author":"Zhao","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2147\/CIA.S305006","article-title":"Potentially inappropriate medication and associated factors among older patients with chronic coronary syndrome at hospital discharge in beijing, China","volume":"16","author":"Zhao","year":"2021","journal-title":"Clin. Interv. Aging"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.946415\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T07:33:48Z","timestamp":1661326428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.946415\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":79,"alternative-id":["10.3389\/fphar.2022.946415"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.946415","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]},"article-number":"946415"}}